ClinConnect ClinConnect Logo
Search / Trial NCT06560450

Research Report: CERITER Clinical Study - Stride One

Launched by CERITER NEDERLAND BV · Aug 16, 2024

Trial Information

Current as of August 02, 2025

Completed

Keywords

Cva (Cerebrovascular Accident) Gait Rehabilitation Gait Analysis Tele Rehabilitation

ClinConnect Summary

Both therapist and patient reported an improvement in the quality of the foot roll-off pattern in 100% of cases. This improvement was also objectively determined in the data measured by Stride One, with an average of 8% improvement on Stride One general quality parameter, and an average of 25% improvement on Stride One specific quality parameter for the specific patient. Furthermore, 89% of patients indicate that using Stride One helps them to understand their physiotherapist better, and 67% of patients indicate that they can practice more and better with Stride One.

Practicing one week wi...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • CVA, residentially admitted to the rehabilitation center in Herk-de-Stad, Belgium
  • Older than 18 years of age
  • Gait problems as a result of the CVA
  • Able to walk safely and independently (possibly with a walking aid)
  • Able to understand and sign an information and consent form
  • Exclusion Criteria:
  • Severe cognitive problems (attention) that make it difficult to understand instructions or follow feedback
  • Hearing problem

About Ceriter Nederland Bv

Ceriter Nederland BV is a forward-thinking clinical trial sponsor dedicated to advancing medical research and innovation. With a strong emphasis on patient safety and ethical standards, Ceriter collaborates with healthcare professionals and research institutions to design and execute clinical trials that drive the development of new therapies and treatment strategies. Leveraging a robust network and expertise in regulatory compliance, Ceriter ensures the efficient management of trial processes, facilitating valuable insights that contribute to the enhancement of patient care and outcomes.

Locations

Hasselt, , Belgium

Patients applied

0 patients applied

Trial Officials

Sarah Meyer

Study Director

Frame Jessa Ziekenhuis

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported